Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Anika Therapeutics Inc. (ANIK) had Days Sales in Receivables of 80.21 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$32.61M |
|
$3.31M |
|
$11.37M |
|
$21.24M |
|
$29.66M |
|
$2.95M |
|
$0.43M |
|
$3.38M |
|
$3.38M |
|
$3.31M |
|
$3.31M |
|
$3.31M |
|
$3.31M |
|
$2.95M |
|
$4.46M |
|
13.33M |
|
13.72M |
|
$0.25 |
|
$0.24 |
|
| Balance Sheet Financials | |
$99.19M |
|
$40.10M |
|
$84.28M |
|
$183.47M |
|
$22.15M |
|
-- |
|
$24.05M |
|
$46.19M |
|
$137.28M |
|
$127.81M |
|
$137.28M |
|
13.38M |
|
| Cash Flow Statement Financials | |
$-5.53M |
|
$-2.52M |
|
$-11.05M |
|
$57.48M |
|
$38.41M |
|
$-19.07M |
|
$8.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
65.15% |
|
9.06% |
|
9.06% |
|
-- |
|
10.36% |
|
10.15% |
|
$-8.41M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.40 |
|
1.12 |
|
|
Days Sales in Receivables |
80.21 |
2.41% |
|
2.59% |
|
1.80% |
|
2.41% |
|
$10.26 |
|
$-0.61 |
|
$-0.40 |
|